Skip to content

sample size

2020.10.13 22:13

WHRIA 조회 수:4262

http://www.quantitativeskills.com/sisa/calculations/samsize.htm

 


https://sphweb.bumc.bu.edu/otlt/mph-modules/bs/bs704_power/bs704_power_print.html

 

 

 

 

Sample Sizes for Two Independent Samples, Continuous Outcome


In studies where the plan is to perform a test of hypothesis comparing the means of a continuous outcome variable in two independent populations, the hypotheses of interest are:

versus

where μ 1 and μ 2 are the means in the two comparison populations. The formula for determining the sample sizes to ensure that the test has a specified power is:

where ni is the sample size required in each group (i=1,2), α is the selected level of significance and Z 1-α /2 is the value from the standard normal distribution holding 1- α /2 below it, and 1- β is the selected power and Z 1-β is the value from the standard normal distribution holding 1- β below it. ES is the effect size, defined as:

where | μ 1 - μ 2 | is the absolute value of the difference in means between the two groups expected under the alternative hypothesis, H1. σ is the standard deviation of the outcome of interest. Recall from the module on Hypothesis Testing that, when we performed tests of hypothesis comparing the means of two independent groups, we used Sp, the pooled estimate of the common standard deviation, as a measure of variability in the outcome.

Sp is computed as follows:

If data are available on variability of the outcome in each comparison group, then Sp can be computed and used to generate the sample sizes. However, it is more often the case that data on the variability of the outcome are available from only one group, usually the untreated (e.g., placebo control) or unexposed group. When planning a clinical trial to investigate a new drug or procedure, data are often available from other trials that may have involved a placebo or an active control group (i.e., a standard medication or treatment given for the condition under study). The standard deviation of the outcome variable measured in patients assigned to the placebo, control or unexposed group can be used to plan a future trial, as illustrated.  

 Note also that the formula shown above generates sample size estimates for samples of equal size. If a study is planned where different numbers of patients will be assigned or different numbers of patients will comprise the comparison groups, then alternative formulas can be used (see Howell3 for more details).

 

 




https://www.statisticshowto.com/what-is-the-continuity-correction-factor/

 

https://www.researchgate.net/publication/271265621_Sample_size_calculation_on_web_can_we_rely_on_the_results

 


https://europepmc.org/article/pmc/pmc4751211

번호 제목 글쓴이 날짜 조회 수
304 fast rcnn WHRIA 2017.01.08 133
303 inception WHRIA 2017.01.23 7197
302 windows faster rcnn WHRIA 2017.02.10 4701
301 JAMA WHRIA 2017.02.11 665
300 bash 문자열 WHRIA 2017.02.13 529
299 linux swap file add WHRIA 2017.05.28 3552
298 계속 실행시키기 nohup & WHRIA 2017.05.29 279
297 aws xrdp WHRIA 2017.05.29 1420
296 record IP camera [1] WHRIA 2017.06.22 2239
295 미래가 보이지 않는다. WHRIA 2017.07.01 365
294 https redirect [1] WHRIA 2017.08.13 995
293 Model Dermatology file WHRIA 2017.12.22 691
292 Windows Subsystem Linux WHRIA 2018.01.01 424
291 Deep neural networks show a superior performance to all 42 dermatologists in onychomycosis diagnosis WHRIA 2018.01.08 1834
290 mxnet WHRIA 2018.01.08 661

Powered by Xpress Engine / Designed by Sketchbook

sketchbook5, 스케치북5

sketchbook5, 스케치북5

나눔글꼴 설치 안내


이 PC에는 나눔글꼴이 설치되어 있지 않습니다.

이 사이트를 나눔글꼴로 보기 위해서는
나눔글꼴을 설치해야 합니다.

설치 취소